Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Teleste: Managers´ transactions – Narjus, Hanno

Teleste CorporationManagers´ transactionsApril 2, 2024, at 9:45 a.m. EEST TELESTE: MANAGERS´ TRANSACTIONS – NARJUS, HANNO Teleste Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Hanno Narjus Position: Other senior manager  Issuer: Teleste Oyj LEI: 743700CJRQRU0007GN59 Notification type: INITIAL NOTIFICATION Reference number: 57185/5/4 ____________________________________________ Transaction date: 2024-03-28 Outside a trading venue Instrument type: SHARE ISIN:

Closing of the strategic combination of Assemblin and Caverion and composition of the Board of Directors

2 April 2024 at 8:30 CET On April 1, Triton completed all legal and administrative proceedings needed to create Assemblin Caverion Group and, subsequently, successfully closed the combination between the previous portfolio companies Assemblin and Caverion. The Parent Company of the new, combined group is Assemblin Group AB (under name change to Assemblin Caverion Group AB), Corp. ID No. 559427-2006, domiciled in Stockholm, Sweden. In connection with the regular Annual General Meeting of Assemblin Group AB on March 27, 2024, Susanne Ekblom and Per Ingemar Persson’s term as Board

As part of CLS expansion in Europe prostate cancer patients have been treated with CLS TRANBERG Thermal Therapy System for the first time in Italy

Lund, Sweden – Clinical Laserthermia Systems AB (publ) (“CLS” or “the Company”) today announced that two patients with localized prostate cancer have been safely treated with the TRANBERG® Thermal Therapy System at the San Luigi Gonzaga University Hospital in Turin, Italy. These are the first patient cases in Italy, and part of CLS commercialization and expansion in Europe.The urology department of the hospital, headed by Professor Francesco Porpiglia, has extensive experience in using US-fusion for targeted prostate biopsies and performs approximately 450 prostatectomies and more than 50

The strategic combination of Caverion and Assemblin is completed

Caverion Corporation Investor News 2 April 2024 at 9:30 EETTriton Investment Advisers LLP, the company managing the entities comprising Triton Fund V (together “Triton”), which indirectly control Crayfish BidCo Oy, completed on 1 April 2024 all legal and administrative proceedings needed to create Assemblin Caverion Group and subsequently successfully closed the combination between the previous portfolio companies Assemblin Group AB (“Assemblin”) and Caverion Corporation (“Caverion”). Crayfish BidCo Oy holds approximately 94.39% of all outstanding shares and votes in Caverion (excluding

Invitation to Epiroc’s results presentation for Q1 2024 on April 23

Stockholm, Sweden: Epiroc AB, a leading productivity and sustainability partner for the mining and construction industries, will publish its Q1 2024 results on Tuesday April 23 at approximately 08.00 CEST. A results presentation for investors, analysts and media will be held at 10.00 CEST.The report will be presented by President and CEO Helena Hedblom and CFO Håkan Folin. It will be held in English and begin with a short presentation of the report followed by a question-and-answer session. To follow the presentation webcast, either access the link here 

Closing of the strategic combination of Assemblin and Caverion and changes in the Board of Directors

On April 1, Triton completed all legal and administrative proceedings needed to create Assemblin Caverion Group and, subsequently, successfully closed the combination between the previous portfolio companies Assemblin and Caverion.The Parent Company of the new, combined group is Assemblin Group AB (under name change to Assemblin Caverion Group AB), Corp. ID No. 559427-2006, domiciled in Stockholm, Sweden. In connection with the regular Annual General Meeting of Assemblin Group AB on March 27, 2024, Susanne Ekblom and Per Ingemar Persson’s term as Board members ended and Mikael Aro (

Viaplay Group and Talpa Network enter linear TV partnership in the Netherlands

· Talpa Network’s SBS9 channel to rebrand as Viaplay TV from 5 April · Channel to show selected content from Viaplay’s premium sports portfolio · Viaplay TV available through all major Dutch TV distributors Viaplay Group and Dutch media company Talpa Network have agreed a linear TV partnership in the Netherlands. Starting 5 April, Talpa Network’s widely available SBS9 linear TV channel will be rebranded as Viaplay TV, and will show selected content from the Viaplay streaming service’s portfolio of premium sports. Viaplay TV’s first live broadcast will be the second free practice

BioStock: Alligator Bioscience on the importance of prolonging life

What does time mean to a person who's cancer might not be cured? Prolonged life can bring hope for alternative treatments, or simply allow more time with loved ones. Alligator Bioscience aim to help patients with pancreatic cancer, through activating the body's own immune system. As the FDA has endorsed a phase III study with the company's lead candidate, BioStock studio asked CEO Søren Bregenholt to expand on the next step and his personal engagement in helping cancerpatients.Watch the interview with CEO Søren Bregenholt at biostock.se : https://www.biostock.

ArcticZymes Technologies ASA - resignation of board member

Tromsø, Norway, 2nd April 2024 - Board member Edgar Koster has informed the board that he will resign from the board with immediate effect for personal reasons.The remaining board complies with the requirements regarding board composition and will still constitute a quorum. Dr Marie Roskrow,  Chairman of the Board,  commented, "on behalf of my colleagues and myself,  I would like thank Edgar very much for his contribution to the Company over the past year and we wish him well for the future." For more information, please contact:Chairman of the BoardDr. Marie Roskrow+44 (0)7496

Voydeya approved in US

2 April 2024 Voydeya approved in the US as add-on therapy to ravulizumab or eculizumab for treatment of extravascular haemolysis in adults with the rare disease PNH Approval of first-in-class, oral, Factor D inhibitor based on results from pivotal ALPHA Phase III trial Voydeya (danicopan) has been approved in the US as add-on therapy to ravulizumab or eculizumab for the treatment of extravascular haemolysis (EVH) in adults with paroxysmal nocturnal haemoglobinuria (PNH).[1] Voydeya is a first-in-class, oral, Factor D inhibitor developed as an add-on to standard-of-care Ultomiris (

AFRY is the trusted partner for TNB Renewables in a new solar power project in Malaysia

TNB Renewables Sdn Bhd has appointed AFRY as the owner’s engineer for the construction of a large-scale solar photovoltaic plant in Kedah, Malaysia, that will provide clean energy to a corporate consumer through a long-term agreement.TNB Renewables Sdn Bhd (TRe) is a fully owned subsidiary of Malaysia’s leading electricity utility company, Tenaga Nasional Berhad (TNB), that has a firm commitment to accelerating the transition to sustainable energy in the country and across Southeast Asia. TRe has chosen AFRY to provide owner’s engineering services on the Corporate Green Power Programme (

FDA accepts Dato-DXd BLA for breast cancer

2 April 2024 Datopotamab deruxtecan Biologics License Application accepted in the US for patients with previously treated metastatic HR-positive, HER2-negative breast cancer Application based on results from the TROPION-Breast01 Phase III trial Additional BLA under review in the US for AstraZeneca and Daiichi Sankyo's datopotamab deruxtecan for patients with advanced nonsquamous non-small cell lung cancer AstraZeneca and Daiichi Sankyo's Biologics License Application (BLA) for datopotamab deruxtecan (Dato-DXd) has been accepted in the US for the treatment of adult patients with

Notice of annual general meeting 2024 in Camurus (publ)

The shareholders of Camurus AB (publ), Reg. No 556667-9105, are hereby invited to the Annual General Meeting (“AGM”) on 8 May 2024 at 17.00 CEST at Elite Hotel Ideon, Scheelevägen 27, Ideon Science Park, 223 63 Lund, Sweden. Registration for the AGM begins at 16.30 CEST. The Board of Directors has decided that shareholders shall be able to exercise their voting rights at the AGM also by postal voting in accordance with the regulations in Camurus’ Articles of Association. Right to participate and notification A) Participation in the meeting room A person who wishes to attend the

PostNord releases ABBA Stamps – celebrating 50 years of music history

Every year, PostNord releases a number of stamps featuring a motif that illustrates someone or something that has meant a little bit extra to Sweden. It can be a person, a happening, or an event stemming from Swedish nature, culture, history, sports, or society. To celebrate 50 years of iconic pop music beloved by listeners worldwide, PostNord has chosen the music group ABBA as a motif this year.ABBA has had a tremendous impact on both Sweden and the global music scene over the past 50 years – a success story that began with the performance of "Waterloo" at the Eurovision Song Contest in

Events during the first quarter, 2024

During the quarter, Wallenstam has completed two new construction projects in Gothenburg and Uppsala as well as the reconstruction and extension of a commercial property in central Gothenburg. All in all, Wallenstam had 830 apartments under construction as of March 31, 2024. Wallenstam’s repurchase of its own shares that started on October 20, 2023 has now ended.The Kv.5 project in Kallebäcks Terrasser, Gothenburg, which comprises 182 apartments, has been completed during the quarter, as has the Kompositören project in Uppsala where the last 69 apartments out of a total of 185 are now

Transaction in Own Shares

    02 April 2024 Vesuvius plc Share Buyback Programme – Transactions in Own Securities   Vesuvius plc (the "Company") announces that it has purchased the following number of its Ordinary Shares of 10p each from Jefferies International Limited (the “Broker”), pursuant to the terms of its Share Buyback Programme announced on 4 December 2023:   +---------------------------------------------------------------+----------+|Date of purchase: |28/03/2024|+-------------------------------------------------------------

Repurchases of shares by Concentric AB during week 13, 2024 – third leg of the buy back completed

Between 25 March 2024 and 28 March 2024 Concentric AB (LEI code 5493002G9GMTKIP3PW19) (“Concentric”) has repurchased in total 13,339 own shares (ISIN: SE0003950864) as part of the repurchase program initiated by the Board. The repurchases form part of the repurchase program of a maximum of 3,519,172 own shares for a total maximum amount of SEK 150,000,000 that Concentric announced on 26 July 2023. The repurchase program, which runs between 31 July 2023 and 31 March 2024, is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 and the Commission Delegated

Invitation to Autoliv’s Q1, 2024 Earnings Call

(Stockholm, Sweden, April 2, 2024) – Autoliv Inc., plans to publish its Financial Report for the first quarter 2024 on Friday, April 26, 2024 at 12:00 Central European Time (CET).The report will be available at www.autoliv.comIn addition, a teleconference will take place the same day. Q1 2024 Earnings Call:Date: April 26, 2024Time: 14:00 – 15:00 CETMain speaker: Mikael Bratt, President & CEO To attend by webcast, please usethe link on our web or the linkbelow:https://edge.media-server.com/mmc/p/u3ygbhjnTo attend by phone, use the linkbelow to

Studsvik appoints new CFO

Studsvik has appointed Peter Teske as Chief Financial Officer and member of the Studsvik Executive Management Group. He will start his appointment 29[th] of April 2024. Peter comes most recently from a position at Skill Scandinavia as CFO. Prior to that, he held various senior positions in the field of economics and finance in both the private and public sectors. "Studsvik is in a period of focus on growth, efficiency and change. Peter will be a reinforcement to the Group with his experience of both finance and change management in various types of businesses," comments Camilla

Metso and Almalyk MMC sign frame agreement for major copper smelter delivery in Uzbekistan

Metso Corporation’s press release on April 2, 2024, at 09:00 a.m. EESTMetso and JSC Almalyk Mining and Metallurgical company (Almalyk MMC) have signed a frame agreement on significant process technology deliveries for Almalyk MMC’s new copper smelter investment in Uzbekistan. The companies have collaborated on the development of minerals processing and metallurgical operations since 2011. Equipment package contracts under the framework agreement will be booked once they have been signed and become effective. We currently estimate that the majority of those contracts will be signed this

Major turnaround 2024 at Neste refinery in Porvoo, Finland about to begin

Neste Corporation, Press Release, 2 April 2024 at 9 a.m. (EET)Neste secures safe and undisrupted operations at its refineries with regularly scheduled maintenance shutdowns, i.e. major turnarounds. At Neste’s refinery in Porvoo, Finland, the preparations for the major turnaround  taking place in April-June began on 1 April with shutdowns of process units. After the refinery shutdown is completed, the actual turnaround works will begin in mid-April and are expected to continue

Teleste Corporation´s conveyance of own shares based on the long-term incentive plan

Teleste CorporationStock exchange releaseApril 2, 2024, at 9:00 a.m. EEST  TELESTE CORPORATION´S CONVEYANCE OF OWN SHARES BASED ON THE LONG-TERM INCENTIVE PLAN A total of 8,628 Teleste Corporation's treasury shares were conveyed without consideration to the key employees participating in the plan period 2021–2023 of Teleste long-term share-based incentive programme. More detailed information about the launch of the plan period and its terms and conditions is available in a stock exchange release published on 11 February 2021. The decision on the directed share issue is based

There are no items matching the current filter
There are no more items matching the current filter
Back to top